Clinical Trial: LH-Guided Recombinant LH Supplementation in Women Undergoing IVF/ICSI

U.S., Nov. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07933341) titled 'LH-Guided Recombinant LH Supplementation in Women Undergoing IVF/ICSI' on Nov. 06.

Brief Summary: The goal of this observational study is to evaluate the relationship between luteinizing hormone (LH)-guided recombinant LH supplementation and IVF outcomes in women aged 21-45 years undergoing their first IVF/ICSI cycle using a gonadotropin-releasing hormone (GnRH) antagonist protocol.

The main questions it aims to answer are:

* Is LH-guided recombinant LH supplementation associated with a higher number of good-quality blastocysts?

* Is LH-guided recombinant LH supplementation associated with a higher clinical pregnancy rate?

Resea...